🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Acute Ischemic Stroke Patients

Effectiveness of Best Care Practices in Acute Stroke in Conventional Hospitalization (BEST CARE ICTUS_HC) NCT07627399NA4 sites📍 Antequera📍 Marbella📍 Ronda University of Malaga · Tests: BEST CARE ICTUS_HC BUNDLE Therapy Evaluation in Patients With Minor Stroke and Large Vessel Occlusion NCT06633809n/a1 site📍 Hangzhou Sir Run Run Shaw Hospital · Tests: Immediate endovascular therapy Effects of Vojta Therapy on Posture and Trunk Control NCT07244952NA1 site📍 Lahore University of Lahore · Tests: Vojta therapy, Routine physical therapy Early Neurological Clinical Recovery, 3 Months After Endovascular Treatment of an Acute Ischemic Stroke NCT02879123n/a1 site📍 Paris Fondation Ophtalmologique Adolphe de Rothschild Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe NCT06825897NA15 sites📍 New Haven📍 Hollywood📍 Miami Santiago Ortega Gutierrez · Tests: Conventional Triage for Mechanical Thrombectomy, Direct Transfer to Angiography Suite (DTAS Triage of Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions-2 NCT05659160n/a4 sites📍 Tianjin📍 Tianjin📍 Tianjin Tianjin Huanhu Hospital · Tests: Endovascular Therapy Inhaled Nitric Oxide in Acute Ischemic Stroke Patients Undergoing Mechanical Thrombectomy NCT05871606Phase 12 sites📍 Charlotte📍 Charlotte Wake Forest University Health Sciences · Tests: iNO A Study of B2065 in Patients With Acute Ischemic Stroke NCT07371624Phase 1, Phase 21 site📍 Beijing Tasly Pharmaceutical Group Co., Ltd · Tests: B2065, Placebo iTBS for Acute Ischemic Stroke After Thrombectomy NCT06941961NA1 site📍 Changchun Yi Yang · Tests: intermittent theta burst stimulation, sham intermittent theta burst stimulation Study of BB-031 in Acute Ischemic Stroke Patients (RAISE) NCT06226805Phase 225 sites📍 Scottsdale📍 Burlingame📍 Long Beach Basking Biosciences, Inc. · Tests: BB-031, Placebo Safety and Efficacy Evaluation of the Ceretrieve Device in the Treatment of AIS Patients NCT06733246NA1 site📍 Heidelberg Ceretrieve Ltd. · Tests: Aspiration 0 Induced Pluripotent Stem Cells-derived Small Extracellular Vesicles May Promote Neurological Function and Improve Cognitive Impairment in Acute Ischemic Stroke Patients NCT07145294Phase 1, Phase 21 site📍 Shanghai Hongmei Wang · Tests: iEV, Basic treatments Acute Ischemic Stroke in Patients With Active Cancer NCT07819526n/a1 site📍 Suita Osaka University NeuroAiD Patient-Reported Outcomes in Patients With Mild to Moderate Ischemic Stroke NCT07828210Phase 41 site📍 Ho Chi Minh City EVD Pharmacy and Medical Company Limited · Tests: MLC901, Standard treatment for acute ischemic stroke the Predictors of Hemorrhagic Transformation Subtypes in Acute Embolic Stroke Patients NCT06653946Phase 41 site📍 Kafr ash Shaykh Kafrelsheikh University · Tests: Alteplase, Alteplase Prognosis and Diagnosis of Spasticity in Acute-post Stroke Patients NCT05179473n/a1 site📍 Montreal McGill University Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset NCT07324837Phase 317 sites📍 Ryazan📍 Chelyabinsk📍 Irkutsk Supergene, LLC · Tests: non-immunogenic staphylokinase, Placebo Research on the Effectiveness of Neurorehabilitation After Stroke NCT06753006NA1 site📍 Samara Neurotechnika · Tests: Neurorehabilitation simulator, Standard course Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke NCT06857487Phase 1, Phase 21 site📍 Beijing Dongzhimen Hospital, Beijing · Tests: Qingre Huatan Formula, Qingre Huatan Formula placebo, Guidelines-based standard care Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY) NCT06157502Phase 382 sites📍 Beijing📍 Chongqing📍 Chongqing Beijing Tiantan Hospital · Tests: Shuxuening Injection, Placebo Safety and Efficacy of J147 in Acute Ischemic Stroke NCT07430917Phase 25 sites📍 Long Beach📍 Rockford📍 Albany Abrexa Pharmaceuticals, Inc. · Tests: J147 Emulsion for Injection, Placebo Oriental Research AlliaNce of Acute Ischemic Stroke Given Endovascular Treatment NCT05024292n/a2 sites📍 Zhangzhou📍 Shanghai Shanghai Jiao Tong University Affiliated Sixth People's Hos… · Tests: rapid local ischemic postconditioning (RL-IPostC) Thrombolysis in Factor Xa-inhibitors Trial NCT06878066Phase 321 sites📍 Aalborg📍 Aarhus📍 Baerum Guri Hagberg · Tests: thrombolysis therapy Efficacy and Safety of PCSK9 Inhibitors in Patients With Large-Artery Atherosclerosis (LAA) Ischemic Stroke NCT07540741n/a1 site📍 Heilongjiang First Affiliated Hospital of Harbin Medical University Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2) NCT07800572Phase 213 sites📍 Anyang📍 Beijing📍 Huzhou Capital Medical University · Tests: Anisodine Hydrobromide, Anisodine Hydrobromide Placebo Minocycline in Stroke Study at Maimonides NCT07237048Phase 2, Phase 31 site📍 Brooklyn Joyce Chen · Tests: Minocycline 200mg The Assessment of Acute /Chronic Phase in Patients With Ischemic Cerebral Stroke Using TCM Diagnostic Tools NCT06342206n/a1 site📍 Changhua China Medical University Hospital Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular Thrombectomy NCT07581210Phase 214 sites📍 Meizhou📍 Luoyang📍 Nanyang Shanghai QuietD Biotechnology Co., Ltd. · Tests: QD202, Placebo UCMSCs as Treatment for Patients With Acute Ischemic Stroke (Stroke Neuroncell-EX) NCT06129175Phase 2, Phase 31 site📍 Cheras Cytopeutics Sdn. Bhd. · Tests: Neuroncell-EX, Placebo Using AI Systems to Optimize the Clinical Outcome of Stroke Patients NCT06828679NA1 site📍 Hong Kong Chinese University of Hong Kong · Tests: Acupuncture, control group, Robotic Training, Neuromuscular Electrical Stimulation Group
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy